Until recently, the focus for the treatment of lung cancer has been on immunotherapy and targeted therapy, but I think that antibody–drug conjugates (ADCs) are going to have a massive role in the management of this disease in the future. READ ARTICLE

Clinical Care Options: Oncology

Authors: Ross Camidge

Read More